To describe the management of PJI due to Thirteen CRIOAcs were selected to participate to the study. Data concerning the management of all the PJI in the year 2019 were retrospectively collected and registered in eCRFs. Inclusion criteria were: ≥ 18 years old patients with Aim
Method
Laboratory records from January 2009 to January 2014 were searched for monomicrobial Aim
Methods
Our hospital is a referral center for Bone and Joint Infection (BJI) with a 15-bed orthopedic unit. Patients benefit from a multidisciplinary team management (surgeons, anesthetists, infectious disease physicians, microbiologists, dietician etc.). Computerized drug prescriptions are performed by anesthetists, surgical residents, surgeons and infectious disease physicians. Since 2015, a pharmacist has been included in ward rounds and in weekly multidisciplinary consultative meetings, where antibiotic treatment strategies are decided for hospitalized patients. This work aimed to assess the impact of a pharmacist in this unit to limit prescription errors. Prospective monocentric study of all pharmacist's advice or interventions during 15 weeks in 2016 and 2017. A complete pharmaceutical analysis of prescriptions is performed twice a week at least. This analysis is based on doses control and drug interactions, but also takes into account biological and clinical data of patients (patient history, renal function, symptoms, adverse effects…). In case of a prescription error, a computerized message and/or a phone call is sent to the prescriber. Each pharmacist's intervention is recorded and classified according to the French Society of Clinical Pharmacy. The pharmacist collected the number of pharmaceutical advice (when spontaneously solicited by any member of the multidisciplinary team), the different types of prescription errors, the pharmacological class associated to these errors, the types of pharmacist's interventions and their impact on prescriptions.Aim
Method
Osteoporosis following ovariectomy has been suggested to modulate bone response to polyethylene wear debris. In this work, we evaluate the influence of estrogen deficiency on experimental particle-induced osteolysis. Polyethylene (PE) particles were implanted onto the calvaria of wild-type (WT), sham-ovariectomized (OVX), OVX mice and OVX mice supplemented with estrogen (OVX+E2) (12 mice per group). Sham-implanted mice served as internal controls. After 14 days, seven skulls per group were analyzed with a high-resolution micro-computed tomography (CT) and by histomorphometry, and for tartrate-specific alkaline phosphatase. Five calvariae per group were cultured for the assay of IL-1, IL-6, TNF- and RANKL secretion using quantitative ELISA. The expression of RANKL and OPG mRNA were evaluated using real-time PCR. As assessed by CT and by histomorphometry, PE particles induced an extensive bone resorption and an intense inflammatory reaction in WT, sham-OVX and OVX+E2 mice. In OVX mice group, these features appeared considerably attenuated. In WT, sham-OVX and OVX+E2 mice, PE particles induced an increase in serum IL-6, in TNF-and RANKL local concentrations, and resulted in a two-fold increase in RANKL/OPG mRNA ratio. Conversely, these parameters remained unchanged in OVX mice after PE implantation. The combination of two well-known bone resorptive mechanisms ultimately attenuated osteolytic response, suggesting a protective effect of estrogen deficiency on particle-induced osteolysis. This paradoxical phenomenon was associated with a downregulation of pro-resorptive cytokines. It is hypothesized that excessive inflammatory response was controlled, illustrated by the absence of increase of serum IL-6 in OVX mice after PE implantation.
Effectiveness of total hip arthroplasty (THA) for acute fracture of the femoral neck is still debated. The purpose of this retrospective controlled study was to compare the results of THA done for fracture of the femoral neck with a similar group of matched THAs done for osteoarthritis (OA). From 1993 to 2000, 25 patients (25 hips) had THA for displaced femoral neck fracture. There were 18 women and 7 men, with a mean age of 73+/− 8.5 years (range, 55 to 93 years). The control group was composed of 25 patients (27 hips) who had THA for primary OA. Patients were matched for age, sex, medical comorbidity, surgical approach, prosthesis, and surgeon. Cemented implants with a Me-PE couple were used in the great majority. All patients had radiographic assessment. Functional results were rated according to the grading system of Merle d’Aubigné. One patient (one hip) was lost to follow-up in each group. The mean follow-up was 6 years (range, 3.5 to 10 years). No revision was performed in this series. Complications included one postoperative dislocation in both groups. At the last follow up evaluation, 21 hips and 23 hips were classified excellent or very good in the “fracture” group and in the control group respectively. No progressive radiolucent line and no osteolysis were recorded. Mean annual PE wear was 0.096 +/− 0.094 (range, 0 to 0.26 mm) in the studied group compared with 0.125+/− 0.095 (range, 0 to 0.24 mm) in the control (p=0.30). THA for acute femoral neck fracture and THA for OA provided comparable mid to long term results in elderly patients.